Saturday, July 11, 2026

pharma · Adenocarcinoma of Lung · Primary Sjögren's Syndrome

Peking University Biologics

Peking University Biologics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
2018 Founded
8 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
2018
Employees
8
Programs
2
Drugs
2
Patents
0
Intelligence · Clinical Trials

Peking University Biologics clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Peking University Biologics programs — each row shows trial ID, program name, phase, status, and indication.

Peking University Biologics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Peking University Biologics.

  1. Furmonertinib — Phase 2

    Clinical update
  2. Tofacitinib — Phase 2

    Clinical update

Trial registry

2 studies